Libo Zhao

6.3k total citations
165 papers, 4.7k citations indexed

About

Libo Zhao is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Libo Zhao has authored 165 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 27 papers in Oncology and 19 papers in Pharmacology. Recurrent topics in Libo Zhao's work include Dendrimers and Hyperbranched Polymers (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Libo Zhao is often cited by papers focused on Dendrimers and Hyperbranched Polymers (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Libo Zhao collaborates with scholars based in China, United States and Hong Kong. Libo Zhao's co-authors include Tongwen Xu, Yiwen Li, Yiyun Cheng, Hsian‐Rong Tseng, Yiyun Cheng, Qinglin Shen, Bin Xiong, Xiaohong Fang, Shuang Hou and Mitch A. Garcia and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Libo Zhao

157 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Zhao China 34 2.0k 1.3k 809 587 522 165 4.7k
Jens Pietzsch Germany 41 1.8k 0.9× 902 0.7× 1.2k 1.5× 586 1.0× 162 0.3× 296 6.1k
Wenwen Li China 38 1.6k 0.8× 469 0.4× 750 0.9× 330 0.6× 250 0.5× 218 4.8k
Song Li United States 43 2.7k 1.3× 1.1k 0.9× 873 1.1× 577 1.0× 178 0.3× 171 5.8k
Jiao Wang China 46 3.4k 1.7× 1.1k 0.8× 1.1k 1.3× 836 1.4× 517 1.0× 245 7.7k
Zimei Wu New Zealand 40 2.3k 1.2× 1.8k 1.3× 426 0.5× 415 0.7× 273 0.5× 179 5.8k
Dongin Kim United States 32 2.2k 1.1× 1.4k 1.1× 416 0.5× 307 0.5× 240 0.5× 74 5.1k
Caitríona M. O’Driscoll Ireland 49 3.3k 1.7× 1.1k 0.8× 801 1.0× 382 0.7× 182 0.3× 131 7.0k
Yanyan Xu China 27 1.1k 0.6× 585 0.4× 309 0.4× 298 0.5× 253 0.5× 139 3.6k
Qin Wang China 40 2.3k 1.2× 654 0.5× 706 0.9× 593 1.0× 167 0.3× 288 6.7k
Fei Yan China 43 2.5k 1.2× 1.2k 0.9× 574 0.7× 838 1.4× 100 0.2× 202 5.4k

Countries citing papers authored by Libo Zhao

Since Specialization
Citations

This map shows the geographic impact of Libo Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Zhao more than expected).

Fields of papers citing papers by Libo Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Zhao. The network helps show where Libo Zhao may publish in the future.

Co-authorship network of co-authors of Libo Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Zhao. A scholar is included among the top collaborators of Libo Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Zhao. Libo Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Rui, Libo Zhao, Yinghui Gao, et al.. (2025). SHAP Analysis of Machine Learning-Based Carotid Atherosclerosis Prediction of Older Adults with OSA, a Multicenter Study. Nature and Science of Sleep. Volume 17. 2351–2367.
2.
3.
Li, Yanming, Bing Hao, Jinliang Li, et al.. (2025). Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A Systematic Review and Model-Based Meta-Analysis. Diabetes Technology & Therapeutics. 27(6). 422–429. 2 indexed citations
4.
Xu, Jiamin, et al.. (2024). Modulation of mercaptopurine intestinal toxicity and pharmacokinetics by gut microbiota. Biomedicine & Pharmacotherapy. 177. 116975–116975. 2 indexed citations
5.
Yang, Ping, Wei Liu, Libo Zhao, et al.. (2024). Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice. International Journal of Antimicrobial Agents. 64(2). 107199–107199. 1 indexed citations
6.
Fan, Kai, Wei Luo, Zhang Li, et al.. (2024). Divergence-Guided Simultaneous Speech Translation. Proceedings of the AAAI Conference on Artificial Intelligence. 38(16). 17799–17807. 2 indexed citations
7.
8.
Gao, Wei, et al.. (2023). Cellular Uptake and Transport Mechanism of 6-Mercaptopurine Nanomedicines for Enhanced Oral Bioavailability. International Journal of Nanomedicine. Volume 18. 79–94. 12 indexed citations
9.
Zhao, Libo, Kai Fan, Wei Luo, et al.. (2023). Adaptive Policy with Wait-k Model for Simultaneous Translation. 1 indexed citations
10.
Sun, Ning, Qing Zhang, Honghao Ma, et al.. (2022). Development and application of an LC-MS/MS method for pharmacokinetic study of ruxolitinib in children with hemophagocytic lymphohistiocytosis. Analytical Methods. 14(23). 2293–2303. 4 indexed citations
11.
12.
Zhang, Qing, et al.. (2022). Population pharmacokinetics of ruxolitinib in children with hemophagocytic lymphohistiocytosis: focus on the drug–drug interactions. Cancer Chemotherapy and Pharmacology. 91(2). 121–132. 1 indexed citations
13.
Cheng, Xiaoling, Lingling Fu, Zhenping Chen, et al.. (2021). Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice. Blood Advances. 5(19). 3799–3806. 12 indexed citations
14.
Liu, Xiaohui, et al.. (2021). Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument. Journal of Clinical Pharmacy and Therapeutics. 46(4). 1155–1165. 5 indexed citations
15.
Liu, Hui, Yonghui Dong, Yutong Gao, et al.. (2018). Hesperetin suppresses RANKL‐induced osteoclastogenesis and ameliorates lipopolysaccharide‐induced bone loss. Journal of Cellular Physiology. 234(7). 11009–11022. 38 indexed citations
16.
Zhao, Liming, Hanfeng Guan, Chao Song, et al.. (2018). YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism. Bone. 110. 177–186. 51 indexed citations
17.
Zhao, Libo, Xiurong Li, Zhiguo Zhang, et al.. (2014). Prevalence, correlates and recognition of depression in Chinese inpatients with cancer. General Hospital Psychiatry. 36(5). 477–482. 30 indexed citations
18.
Zhao, Libo, Yi‐Tsung Lu, Fuqiang Li, et al.. (2013). High‐Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber‐Embedded Microchip for Whole Exome Sequencing. Advanced Materials. 25(21). 2897–2902. 133 indexed citations
19.
Zhang, Nangang, Yuliang Deng, Qidong Tai, et al.. (2012). Electrospun TiO2 Nanofiber‐Based Cell Capture Assay for Detecting Circulating Tumor Cells from Colorectal and Gastric Cancer Patients. Advanced Materials. 24(20). 2756–2760. 301 indexed citations
20.
Huang, Ying, Libo Zhao, Ting Hu, et al.. (2007). Pharmacokinetics and metabolism of neferine in rats after a single oral administration. Biopharmaceutics & Drug Disposition. 28(7). 361–372. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Pietzsch Breakdown of academic impact, for papers by Wenwen Li Breakdown of academic impact, for papers by Song Li Breakdown of academic impact, for papers by Jiao Wang Breakdown of academic impact, for papers by Zimei Wu Breakdown of academic impact, for papers by Dongin Kim Breakdown of academic impact, for papers by Caitríona M. O’Driscoll Breakdown of academic impact, for papers by Yanyan Xu Breakdown of academic impact, for papers by Qin Wang Breakdown of academic impact, for papers by Fei Yan
Rankless by CCL
2026